Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
12/02/2008US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot
12/02/2008US7459142 High viscosity embolizing compositions comprising prepolymers
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2372912C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
12/02/2008CA2317565C Competitive inhibitors of glyoxalase i and method of generating such competitive inhibitors inside tumor cells
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them
12/02/2008CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use
11/2008
11/27/2008WO2008144507A2 Spirooxindole inhibitors of aurora kinase
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144423A2 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
11/27/2008WO2008144263A1 Potent indole-3-carbinol-derived antitumor agents
11/27/2008WO2008144253A1 Protein kinase inhibitors and methods for using thereof
11/27/2008WO2008144223A2 Triazolyl aminopyrimidine compounds
11/27/2008WO2008144222A2 Triazolyl aminopyrimidine compounds
11/27/2008WO2008144062A1 Csf-1r inhibitors, compositions, and methods of use
11/27/2008WO2008144045A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/27/2008WO2008143759A1 Pyrimidinones as casein kinase ii (ck2) modulators
11/27/2008WO2008143709A2 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/27/2008WO2008143706A2 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment
11/27/2008WO2008143677A1 Stable solid elsamitrucin salts suitable for pharmaceutical formulations
11/27/2008WO2008143665A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
11/27/2008WO2008143255A1 Method for production of cell population
11/27/2008WO2008143014A1 Therapeutic agent for cancer
11/27/2008WO2008142862A1 Anticancer therapy by transplanting vascular endothelial progenitor cells
11/27/2008WO2008142513A2 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
11/27/2008WO2008142303A2 Use of an anti-cxcr4 antibody for treating cancer
11/27/2008WO2008142165A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008WO2008142157A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008WO2008142031A1 P38alpha as a therapeutic target in bladder carcinoma
11/27/2008WO2008141975A1 Spiroindolinone derivatives
11/27/2008WO2008141917A1 3,3-spiroindolinone derivatives
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008WO2008141796A1 Treatment of ddr1 positive cancer using imatinib
11/27/2008WO2008141731A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/27/2008WO2008141523A1 A strain capable of producing arginine deiminase and the use thereof
11/27/2008WO2008141496A1 Sustained-release system for epo and gm-csf
11/27/2008WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
11/27/2008WO2008141449A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/27/2008WO2008141448A1 Mutant reoviruses and methods of making and using
11/27/2008WO2008121742A3 Inhibitors of bruton's tyrosine kinase
11/27/2008WO2008110624A3 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors
11/27/2008WO2008109532A3 Nucleic acid compounds for inhibiting fas gene expression and uses thereof
11/27/2008WO2008087329A3 New drug for treating gastric cancer
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008080037A3 Carotenoids of enhanced bioavailability
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008061671A3 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
11/27/2008WO2008061647A8 Use of a compound as vegf inhibitor
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008WO2008032153A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008US20080293944 Piperazinyl Compounds
11/27/2008US20080293816 Use of 2,5-Dihydroxybenzenesulphonic Acid in the Production of Medicaments for the Treatment of Angiodependent Diseases Such as Cancer and Psoriasis
11/27/2008US20080293808 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof
11/27/2008US20080293800 Cytotoxic Compounds and Conjugates
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293796 Parenteral and oral formulations of benzimidazoles
11/27/2008US20080293795 Combination therapy with parp inhibitors
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293784 Epothilones c, d, e and f, preparation and compositions
11/27/2008US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
11/27/2008US20080293781 Salicylic Acid Derivatives
11/27/2008US20080293769 Polymorphs of a C-Met/Hgfr Inhibitor
11/27/2008US20080293766 Small-molecule inhibitors of the androgen receptor
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293764 Lpa receptor antagonist
11/27/2008US20080293759 Method for Treating Cancer Based on the Modulation of Calcineurin
11/27/2008US20080293755 Steroidal alkaloids that can be used in the treatment of hedgehog pathway related disorders, particularly cancer and psoriasis
11/27/2008US20080293754 Cyclopamine analogs
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293744 Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
11/27/2008US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease
11/27/2008US20080293738 Formulation of Quinolinones
11/27/2008US20080293733 Axl kinase inhibitors
11/27/2008US20080293719 Pyridiazinone Derivatives for the Treatment of Tumours
11/27/2008US20080293714 Tec Kinase Inhibitors
11/27/2008US20080293712 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
11/27/2008US20080293711 Chemokine receptor modulators
11/27/2008US20080293706 Quinoxaline derivatives as pi3 kinase inhibitors
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293696 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
11/27/2008US20080293687 Benzamide Compounds
11/27/2008US20080293682 Novel Betulinic Acid Derivatives
11/27/2008US20080293672 Lipid conjugates in the treatment of disease
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293661 Method for treating chronic lymphoid leukemia
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
11/27/2008US20080293651 Cytosine nucleoside analogs and isoflavones and uses thereof
11/27/2008US20080293648 Compositions and Methods for Cancer Treatment
1 ... 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 ... 2211